Correlation Between AstraZeneca PLC and Fragbite Group

Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Fragbite Group at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Fragbite Group into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AstraZeneca PLC and Fragbite Group AB, you can compare the effects of market volatilities on AstraZeneca PLC and Fragbite Group and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Fragbite Group. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Fragbite Group.

Diversification Opportunities for AstraZeneca PLC and Fragbite Group

-0.31

Correlation Coefficient

AstraZeneca PLC  Fragbite Group

Very good diversification

The 3 months correlation between AstraZeneca and Fragbite is -0.31. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and Fragbite Group AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fragbite Group AB and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC are associated (or correlated) with Fragbite Group. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fragbite Group AB has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Fragbite Group go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Fragbite Group

Assuming the 90 days trading horizon AstraZeneca PLC is expected to under-perform the Fragbite Group. But the stock apears to be less risky and, when comparing its historical volatility, AstraZeneca PLC is 86.05 times less risky than Fragbite Group. The stock trades about -0.15 of its potential returns per unit of risk. The Fragbite Group AB is currently generating about 0.14 of returns per unit of risk over similar time horizon. If you would invest  2.60  in Fragbite Group AB on September 22, 2024 and sell it today you would earn a total of  747.40  from holding Fragbite Group AB or generate 28746.15% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	97.78%
Values	Daily Returns

AstraZeneca PLC  vs.  Fragbite Group AB

AstraZeneca PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Fragbite Group AB

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Fragbite Group AB are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Fragbite Group unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with AstraZeneca PLC and Fragbite Group

The main advantage of trading using opposite AstraZeneca PLC and Fragbite Group positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Fragbite Group can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fragbite Group will offset losses from the drop in Fragbite Group's long position.

The idea behind AstraZeneca PLC and Fragbite Group AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.